Adenovirus mediated vascular endothelial growth factor gene transfer protection dopaminergic neurons in parkinson's disease: Experiment with rats

National Medical Journal of China

Volumn 86, Issue 29, 2006, Pages 2054-2059

  Tian, You Yong ^a   Sun, Sheng Gang ^b   Wang, Jia Ning ^b   Tang, Cui Ju ^b   Feng, Yuan ^b   Wang, Lan ^b   Chen, Xiao Wu ^b   Qiao, Xian ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NONE

Author keywords

Endothelial growth factors; Gene therapy; Gene transfer techniques; Parkinson disease

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; HOMOVANILLIC ACID; LAMININ; TYROSINE 3 MONOOXYGENASE; VASCULOTROPIN 165;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; GLIA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; SUBSTANTIA NIGRA; TREATMENT OUTCOME; VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; MALE; NEURONS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33748175953     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chinese source. 2004, 18:36-40.
2. Chinese source. 2005, 38:346-347.
3. Cunningham LA, Su C. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. Exp Neurol, 2002, 174:230-242.
4. Chinese source. 2001, 22:1384-1386.
5. Chinese source. 2002, 6:70-71.
6. Azzouz M, Ralph GS, Storkebaum E, et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature, 2004, 429:413-417.
7. Yasuhara T, Shingo T, Kobayashi K, et al. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci, 2004, 19:1494-1504.
8. Silverman WF, Krum JM, Mani N, et al. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience, 1999, 90:1529-1541.
9. Chinese source. 2002, 20:156-158.
10. Chinese source. 1996, 7:11-13.
11. Alicia BB, Frédéric R, Phillippe C, et al. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc Natl Acad Sci USA, 1997, 94:8818-8823.
12. Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays, 2004, 26:943-954.
13. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal. J Mol Neurosci, 2000, 14:197-203.
14. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA, 2000, 97:10242-10247.
15. Matsuzaki H, Tamatani M, Yamaguchi A, et al. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J, 2001, 15:1218-1220.
16. Svensson B, Peters M, Konig HG, et al. Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J Cereb Blood Flow Metab, 2002, 22:1170-1175.